Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Broader market helping biotech stocks stage a turnaround.

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Sep 20, 2022 10:07am

135 Views

Post# 34973494

RE:RE:RE:RE:RE:Broader market helping biotech stocks stage a turnaround.

Well then goodbye to you. Why stick around if you believe in what you say? Those who are intent on trolling always seem to fall back on their freedom to speech even though they have nothing of particular value to say.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects